Vaccine and Therapeutic Delivery by using Engineering Recombinant Extracellular Transport Vesicles 

Molecular Mechanisms, EV-Engineering and Therapeutic Delivery, Precision Extracellular Vesicle Forum

Cambridge, United Kingdom, October 23, 2024

A Matrix 2 Protein Vaccine from Bacterial Vesicles Protects Against Diverse Strains of Influenza 

Options XII for the Control of Influenza 

Brisbane, Australia September 30, 2024

Can Recombinant Extracellular Vesicles Be An Alterative Technology To Exosomes? 

Cell & Gene Therapy Manufacturing & Commercialization US, BioProcess International

Boston, MA September 18, 2024

Nanovesicle Display of a Universal Influenza Vaccine Candidate Protects against Diverse Strains of Influenza

Eighteenth Vaccine Congress 

Lisbon, Portugal, September 8-12, 2024

Microbial nano-vesicles Derived from Probiotic Cell Lines for Drug and Vaccine Delivery

Institute of Medical Sciences, University of Aberdeen 

Aberdeen, Scotland, UK,  June 4, 2024

Extracellular Transport Vesicles for Cell-specific Cargo Delivery and Vaccines. 

Exosomes Europe International Bioprocessing Summit 

London, United Kingdom, June 6, 2024

Vaccine and Therapeutic Delivery with Recombinant Nanovesicles

Formulation UK 2024 Congress, Oxford Global Conferences

Hammersmith, London, United Kingdom April 25, 2024

Exploring Outer Membrane Vesicles: From Analysis to Therapeutic Promise 

PepTalk Revolutionizing the Future of Biotherapeutics

San Diego, CA, January 19, 2024

Maximizing Capital Efficiency By Balancing Internal Capabilities And External CRO’s. Strategic Partnerships, Investment and Collaborations

Proventa International’s 10^th Annual Drug Discovery Biology Strategy Meeting East Coast USA 2023

Cambridge, MA, November 7, 2023

Can Recombinant Extracellular Vesicles Be An Alternative Technology To Exosomes?

BioProcess International

Boston, Sept 18, 2023

The Challenges & Opportunities for the Future of Therapeutics & Vaccines

Keynote Speaker, Phenomenex Innovation Center Symposium

Mansfield, MA, Sept 13, 2023

Scale Up of Extra-cellular Vesicles Derived from Probiotic Cells and Their Role in Immuno-Oncology

5^th Exosome Based Therapeutic Development Summit

Boston, Sept 5-7, 2023

A Recombinant Influenza Vaccine Made from Membrane Vesicles

15th Annual Bioprocessing Summit, Vaccine Development and Manufacturing Conference

Boston, August 14-15, 2023

Therapeutic Delivery with Recombinant Nano-Vesicles

3^rd Gene and Cell Therapies CMC, CGT, Vector Manufacturing

Vienna, June 20-21, 2023

Structure and Function of a Broad-strain Influenza Vaccine using Nano-vesicles

Vaccine Summit Boston 2023

Waltham, MA, May 21-24, 2023

Optimizing Cell Line Expression Using Microbial Factories for Better Scale-Up

Novel Cell Line Engineering and Development Summit

Boston, MA, May 10-11, 2023

Can Recombinant Extracellular Vesicles be an Alternative Technology to Exosomes?

Applications of Exosomes 2023

Digital Event, March 29, 2023

Targeting Specific Cells with Recombinant Vesicles

Targeted Intracellular Delivery Summit 2023

Boston, March 7-9, 2023

Recombinant Extracellular Vesicles for Therapeutic Cell Targeting and Novel Vaccines

Institute of Pharmaceutical Sciences

Zürich, February 14, 2023

Transformational Vaccines and Therapeutics with Recombinant Extracellular Vesicles

6^th Annual Cell & Gene Therapy Innovation Leaders Summit 2023

Berlin, February 15, 2023

Barracuda Bowl 2022 HealthTech Pitch Event

Boston, October 3, 2022